astrazeneca-oxford covid-19 vaccine up to 90% effective, late stage trials show
Published 3 years ago • 142K plays • Length 2:11Download video MP4
Download video MP3
Similar videos
-
1:38
phase 2 results of oxford, astrazeneca vaccine trial show promising results
-
1:55
astrazeneca may have "included outdated information" in covid-19 vaccine trial report
-
3:17
oxford/astrazeneca covid-19 vaccine can be up to 90% effective
-
2:02
astrazeneca says trial data from u.s. study on its covid-19 vaccine shows it's 79% effective
-
3:57
first american dosed with oxford-astrazeneca phase three covid-19 vaccine speaks out
-
9:10
major european nations suspend astrazeneca vaccination over fears of side effects - bbc news
-
4:25
gravitas | astrazeneca to withdraw its covid vaccines worldwide | wion news
-
3:54
dad who suffered brain injury days after getting covid vaccine sues astrazeneca
-
0:22
astrazenaca: covid-19 vaccine "highly effective" in late-stage trials
-
7:47
infectious disease specialist explains why astrazeneca's covid-19 vaccine can vary in effectivene…
-
3:39
oxford vaccine news offers hope as covid-19 spikes prompt school closures and business restrictio…
-
1:50
astrazeneca says its covid-19 vaccine is safe and highly effective after u.s. clinical trial
-
2:46
oxford-astrazeneca vaccine showing effectiveness in older adults
-
4:33
astrazeneca vaccine shows promise in reducing the spread of covid-19 as concern grows over virus …
-
2:47
coronavirus vaccine trial shows promising results but hurdles remain
-
4:20
astrazeneca vaccine brings more hope as hospitalizations soar
-
1:27
astrazeneca says its covid-19 vaccine shows it is 'highly effective'
-
1:55
u.k. becomes first country to approve oxford-astrazeneca vaccine
-
9:35
doctor on astrazeneca's covid-19 vaccine trial results, risk of spring break surge
-
9:45
astrazeneca pauses clinical trial of covid-19 vaccine
-
6:07
u.s. study finds astrazeneca vaccine 79% effective against symptomatic covid-19
-
7:56
doctor weighs in on astrazeneca pausing its coronavirus vaccine trial